To assay the effect of 177Lu-DOTATATE treatment on APC tumor infiltration and capacity to present tumor antigens, we used flow cytometry and immunohistochemistry to look for CD86 expressing cells in tumor preparations. Here, CD86 is linked to neoplasm.